Regulatory Updates
🇺🇸 FDA Page 10FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 109–120 of 382 articles
The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities in 2024
A Brief History of Major Events in Oncology
ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come
Uncertain FDA Leadership Raises Stakes in Clinical Trials: A Strategic Overview
NIH Funding Cuts Hamper Ebola Preparedness and Global Health Security
FDA Approves Oral Nilotinib Tablets for Ph+ CML: A New Era for Treatment
FDA Approves Xocova: A Catalyst for Pharmaceutical M&A and Licensing
Cencora-Kite Agreement: A New Era for CAR T-cell Therapy Commercialization
FDA Grants Priority Review to Giredestrant for ER+/HER2- Breast Cancer
FDA's Shifting Tides: Navigating Clinical Trials Amidst Regulatory Uncertainty
Munck Wilson Mandala Expands to Fort Worth, Taps Life Sciences Leader
Fulcrum Therapeutics Stock Plummets 54% Following Sickle Cell Drug Discontinuation